ArticleJCO clinical cancer informatics2021
Development and Use of Natural Language Processing for Identification of Distant Cancer Recurrence and Sites of Distant Recurrence Using Unstructured Electronic Health Record Data.
Article in JCO clinical cancer informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Evolution of Breast Cancer Recurrence Risk Prediction: A Systematic Review of Statistical and Machine Learning-Based Models.JCO clinical cancer informatics · 2023Pooled it
- Using co-design to develop actionable strategies to identify and follow-up on breast cancer survivors in primary care.BMC health services research · 2026Trial
- Epidemiological Assessment of Oral and Oropharyngeal Squamous Cell Carcinomas Before, During, and After the COVID-19 Pandemic, 2018-2024.Journal of clinical medicine · 2026Article
- Detection of cancer recurrence from Thai-English electronic medical records using sentence embeddings.BMJ health & care informatics · 2026Article
- Bridging the evidence gap in trial inclusion with real world safety profile assessment in relapsed/refractory multiple myeloma patients.BMC cancer · 2026Article
- Longitudinal Language-Model Reasoning Enables Automated Labeling of Lung Cancer Recurrence from Unstructured Clinical Records.Research square · 2026Article
- Review
- Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges.MedComm · 2025Review
- Integrating a Shareable Artificial Intelligence Model Into Clinical Research for Cancer Recurrence in Patients With Breast and Colorectal Cancer.JCO clinical cancer informatics · 2025Article
- From manual clinical criteria to machine learning algorithms: Comparing outcome endpoints derived from diverse electronic health record data modalities.PLOS digital health · 2025Article
- Using Large Language Models to Automate Data Extraction From Surgical Pathology Reports: Retrospective Cohort Study.JMIR formative research · 2025Article
- An Artificial Intelligence Pipeline for Hepatocellular Carcinoma: From Data to Treatment Recommendations.International journal of general medicine · 2025Review
- Automated Identification of Breast Cancer Relapse in Computed Tomography Reports Using Natural Language Processing.JCO clinical cancer informatics · 2024Article
- Breast cancer learning health system: Patient information from a data and analytics platform characterizes care provided.Learning health systems · 2024Article
- Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale.JCO clinical cancer informatics · 2024Article
- Development of an Automatic Rule-Based Algorithm for the Detection of Ovarian Cancer Recurrence From Electronic Health Records.JCO clinical cancer informatics · 2024Article
- Automatic Detection of Distant Metastasis Mentions in Radiology Reports in Spanish.JCO clinical cancer informatics · 2024Article
- Artificial intelligence across oncology specialties: current applications and emerging tools.BMJ oncology · 2024Review
- Leveraging Large Language Models for Thyroid Nodule Information Extraction and Matching Across Medical Reports.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024Article
- DeepPhe-CR: Natural Language Processing Software Services for Cancer Registrar Case Abstraction.medRxiv : the preprint server for health sciences · 2023Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
purposeLarge-scale analysis of real-world evidence is often limited to structured data fields that do not contain reliable information on recurrence status and disease sites. In this report, we describe a natural language processing (NLP) framework that uses data from free-text, unstructured reports to classify recurrence status and sites of recurrence for patients with breast and hepatocellular carcinomas (HCC).
methodsUsing two cohorts of breast cancer and HCC cases, we validated the ability of a previously developed NLP model to distinguish between no recurrence, local recurrence, and distant recurrence, based on clinician notes, radiology reports, and pathology reports compared with manual curation. A second NLP model was trained and validated to identify sites of recurrence. We compared the ability of each NLP model to identify the presence, timing, and site of recurrence, when compared against manual chart review and International Classification of Diseases coding.
resultsA total of 1,273 patients were included in the development and validation of the two models. The NLP model for recurrence detects distant recurrence with an area under the curve of 0.98 (95% CI, 0.96 to 0.99) and 0.95 (95% CI, 0.88 to 0.98) in breast and HCC cohorts, respectively. The mean accuracy of the NLP model for detecting any site of distant recurrence was 0.9 for breast cancer and 0.83 for HCC. The NLP model for recurrence identified a larger proportion of patients with distant recurrence in a breast cancer database (11.1%) compared with International Classification of Diseases coding (2.31%).
conclusionWe developed two NLP models to identify distant cancer recurrence, timing of recurrence, and sites of recurrence based on unstructured electronic health record data. These models can be used to perform large-scale retrospective studies in oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.